John Bomalaski
Corporate Officer/Principal bij POLARIS GROUP
Actieve functies van John Bomalaski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| POLARIS GROUP | Corporate Officer/Principal | 01-01-2007 | - |
| Directeur/Bestuurslid | 15-04-2006 | - | |
EnzymeRx LLC
 EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Hoofd Techniek/Wetenschap/O&O | - | - |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | 18-12-2009 | - | |
| DRX USA | Directeur/Bestuurslid | - | - |
| DesigneRx Europe Ltd. | Directeur/Bestuurslid | - | - |
| Polaris Group Korea Ltd. | Directeur/Bestuurslid | - | - |
Loopbaan van John Bomalaski
Eerdere bekende functies van John Bomalaski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Pennsylvania | Corporate Officer/Principal | - | - |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - | - |
Opleiding van John Bomalaski
| St. Louis University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Spanje | 2 |
| Taiwan | 2 |
Operationeel
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POLARIS GROUP | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
| DRX USA | |
| DesigneRx Europe Ltd. | |
| Polaris Group Korea Ltd. |
- Beurs
- Insiders
- John Bomalaski
- Ervaring
